JPH04106469A - Testing device - Google Patents
Testing deviceInfo
- Publication number
- JPH04106469A JPH04106469A JP22587690A JP22587690A JPH04106469A JP H04106469 A JPH04106469 A JP H04106469A JP 22587690 A JP22587690 A JP 22587690A JP 22587690 A JP22587690 A JP 22587690A JP H04106469 A JPH04106469 A JP H04106469A
- Authority
- JP
- Japan
- Prior art keywords
- reagent layer
- reagent
- test device
- free radical
- radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 37
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 54
- 239000002516 radical scavenger Substances 0.000 claims abstract description 18
- 229940123457 Free radical scavenger Drugs 0.000 claims description 17
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 12
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 claims description 9
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 8
- 108010024636 Glutathione Proteins 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- 229960003180 glutathione Drugs 0.000 claims description 6
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 claims description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 abstract description 13
- 239000000126 substance Substances 0.000 abstract description 9
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 238000004040 coloring Methods 0.000 abstract description 7
- 239000011148 porous material Substances 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000011521 glass Substances 0.000 abstract description 4
- 239000000049 pigment Substances 0.000 abstract description 4
- 239000011347 resin Substances 0.000 abstract description 4
- 229920005989 resin Polymers 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 43
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 21
- 102000003992 Peroxidases Human genes 0.000 description 13
- 108040007629 peroxidase activity proteins Proteins 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- -1 cation radical Chemical class 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 239000000975 dye Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 108010089254 Cholesterol oxidase Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 108010055297 Sterol Esterase Proteins 0.000 description 6
- 102000000019 Sterol Esterase Human genes 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- HCAUQPZEWLULFJ-UHFFFAOYSA-N benzo[f]quinoline Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=N1 HCAUQPZEWLULFJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 108010090622 glycerol oxidase Proteins 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- YVOQADGLLJCMOE-UHFFFAOYSA-N n-[6-(aziridine-1-carbonylamino)hexyl]aziridine-1-carboxamide Chemical compound C1CN1C(=O)NCCCCCCNC(=O)N1CC1 YVOQADGLLJCMOE-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- SVNCRRZKBNSMIV-UHFFFAOYSA-N 3-Aminoquinoline Chemical compound C1=CC=CC2=CC(N)=CN=C21 SVNCRRZKBNSMIV-UHFFFAOYSA-N 0.000 description 1
- QYIMZXITLDTULQ-UHFFFAOYSA-N 4-(4-amino-2-methylphenyl)-3-methylaniline Chemical compound CC1=CC(N)=CC=C1C1=CC=C(N)C=C1C QYIMZXITLDTULQ-UHFFFAOYSA-N 0.000 description 1
- YRUPBAWWCPVHFT-UHFFFAOYSA-N 4-(4-hydroxyanilino)phenol Chemical compound C1=CC(O)=CC=C1NC1=CC=C(O)C=C1 YRUPBAWWCPVHFT-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 108010000659 Choline oxidase Proteins 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010077078 Creatinase Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 108010028658 Leucine Dehydrogenase Proteins 0.000 description 1
- WZKXBGJNNCGHIC-UHFFFAOYSA-N Leucomalachite green Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=CC=C1 WZKXBGJNNCGHIC-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 108090000553 Phospholipase D Proteins 0.000 description 1
- 229920001311 Poly(hydroxyethyl acrylate) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108090000612 Proline Oxidase Proteins 0.000 description 1
- 102000004177 Proline oxidase Human genes 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- KAPCRJOPWXUMSQ-UHFFFAOYSA-N [2,2-bis[3-(aziridin-1-yl)propanoyloxymethyl]-3-hydroxypropyl] 3-(aziridin-1-yl)propanoate Chemical compound C1CN1CCC(=O)OCC(COC(=O)CCN1CC1)(CO)COC(=O)CCN1CC1 KAPCRJOPWXUMSQ-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- OXXBXDKKLWBUEJ-UHFFFAOYSA-N aziridin-1-yl propanoate Chemical compound CCC(=O)ON1CC1 OXXBXDKKLWBUEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- NYOXRYYXRWJDKP-GYKMGIIDSA-N cholest-4-en-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 NYOXRYYXRWJDKP-GYKMGIIDSA-N 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-LSOMNZGLSA-N cinchonine Chemical compound C1=CC=C2C([C@@H]([C@H]3N4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-LSOMNZGLSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000013080 microcrystalline material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000004986 phenylenediamines Chemical class 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 1
- JLABKOUORPVZCA-UHFFFAOYSA-N sodium;1,4-dibutoxy-1,4-dioxobutane-2-sulfonic acid Chemical compound [Na+].CCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCC JLABKOUORPVZCA-UHFFFAOYSA-N 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は、検体中の特定成分を呈色反応により検出する
試験具に関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a test device for detecting a specific component in a specimen by a color reaction.
〈従来の技術〉
検体中の特定成分、例えば、血液中のグルコース、コレ
ステロール、または尿中のグルコース、ヘモグロビン等
を検出するに際しては、その特定成分と反応して呈色す
る試薬が担持された試薬層を有する試験具が用いられる
。<Prior art> When detecting a specific component in a specimen, such as glucose or cholesterol in blood, or glucose or hemoglobin in urine, a reagent carrying a reagent that reacts with the specific component to develop a color is used. A test device with layers is used.
この試験具における呈色強度(色濃度)は、検体中の特
定成分の量に応じたものとなるため、試験具の呈色強度
を測定することにより、検体中の特定成分を定量するこ
とができる。The color intensity (color density) of this test device depends on the amount of the specific component in the sample, so it is possible to quantify the specific component in the sample by measuring the color intensity of the test device. can.
例えば、検体中の糖量を測定する場合の試薬層の発色原
理は、下記式に示すように、検体中のグルコースと外気
より取り込まれる酸素がグルコースオキシダーゼ(GO
D)という酵素によりグルコン酸と過酸化水素に分解さ
れ、この過酸化水素がペルオキシダーゼ(POD)とい
う酵素により水と活性酸素とに分解され、この活性酸素
が色原体(発色剤)と反応して色素となるものである。For example, when measuring the amount of sugar in a sample, the coloring principle of the reagent layer is as shown in the formula below.
It is decomposed into gluconic acid and hydrogen peroxide by an enzyme called D), and this hydrogen peroxide is decomposed into water and active oxygen by an enzyme called peroxidase (POD), and this active oxygen reacts with a chromogen (color former). It becomes a pigment.
GOD
グルコース+0□−m−グルコン酸+H2O20D
H202−[0] +H20
[0]十色原体−色素
また、総コレステロール量を測定する場合の試薬層の発
色原理は、下記式に示すように、検体中のコレステロー
ルエステルがコレステロールエステラーゼ(COE)に
より、コレステロールと遊離脂肪酸に分解され、このコ
レステロールと検体中のコレステロールは、コレステロ
ールオキシダーゼ(COD)によりΔ4−コレステノン
と過酸化水素に分解され、この過酸化水素がペルオキシ
ダーゼ(POD)により水と活性酸素とに分解され、こ
の活性酸素が色原体(発色剤)と反応して色素となるも
のである。GOD glucose +0 Cholesterol ester in the sample is decomposed into cholesterol and free fatty acids by cholesterol esterase (COE), and this cholesterol and cholesterol in the sample are decomposed into Δ4-cholestenone and hydrogen peroxide by cholesterol oxidase (COD), and this peroxide Hydrogen is decomposed into water and active oxygen by peroxidase (POD), and this active oxygen reacts with a chromogen (coloring agent) to become a pigment.
CUE −
コレステロールエステル −−−→コレス10−ル+遊
離脂肪酸OD
コレステロ−ルナ02−−−− Δ 4−コレステノ
ン+H2O2OD
H20,−[0コ + HzO
[0]十色原体−色素
このような試験具においては、試験具の製造時や未使用
の状態での保存中に、試薬層が発色してしまうという問
題がある。CUE - Cholesterol ester - - → Cholesterol 10-L + Free fatty acid OD Cholesterol - Luna 02 - - - Δ 4-Cholestenone + H2O2OD H20, - [0 Co + HzO [0] Decachromogen - Pigment like this A problem with test devices is that the reagent layer develops color during the manufacture of the test device or during storage in an unused state.
特に、発色剤としてロイコ色素を用いたものについては
、感度が高いため、その分径時安定性が劣り、保存中等
に発色するという現象が顕著である。In particular, those using leuco dyes as color formers have high sensitivity, so their stability during separation is poor, and the phenomenon of color development during storage is noticeable.
〈発明が解決しようとする課題〉
本発明は、上述した従来技術の欠点に鑑みてなされたも
ので、その目的は、経時安定性に優れる試験具を提供す
ることにある。<Problems to be Solved by the Invention> The present invention has been made in view of the above-mentioned drawbacks of the prior art, and its purpose is to provide a test device with excellent stability over time.
く課題を解決するための手段〉
このような目的は、下記(1)〜(4)の本発明により
達成される。Means for Solving the Problems> Such objects are achieved by the following inventions (1) to (4).
(1)発色剤としてロイコ色素を含む試薬を担持した試
薬層を有する試験具であって、前記試薬層中に、遊離基
捕獲剤を含有することを特徴とする試験具。(1) A test device having a reagent layer supporting a reagent containing a leuco dye as a coloring agent, wherein the reagent layer contains a free radical scavenger.
(2)前記ロイコ色素は、ベンジジンまたはベンジジン
系化合物である上記(1)に記載の試験具。(2) The test device according to (1) above, wherein the leuco dye is benzidine or a benzidine-based compound.
(3)前記遊離基捕獲剤は、ジチオエリスリトール、ジ
チオスレイトール、グルタチオンおよび2−メルカプト
エタノールよりなる群から選ばれた少なくとも1種であ
る上記(1)または(2)に記載の試験具。(3) The test device according to (1) or (2) above, wherein the free radical scavenger is at least one selected from the group consisting of dithioerythritol, dithiothreitol, glutathione, and 2-mercaptoethanol.
(4)前記遊離基捕獲剤の添加量は、前記試薬層III
+2当り、1〜1000mgである上記(1)〜(3)
のいずれかに記載の試験具。(4) The amount of the free radical scavenger added is determined in the reagent layer III.
(1) to (3) above, which is 1 to 1000 mg per +2
The test device described in any of the above.
〈作用〉
本発明者等は、試験具の製造時や保存中に試薬層が発色
する原因について研究したところ、次のようなことがわ
かった。<Function> The present inventors studied the cause of color development of the reagent layer during the manufacture and storage of the test device, and found the following.
例えば、ロイコ色素の一例である〇−トリジンは、下記
式のように活性酸素と反応して酸化型o−トリジンとな
り発色する。For example, 0-tolidine, which is an example of a leuco dye, reacts with active oxygen to form oxidized o-tolidine as shown in the following formula and develops a color.
(0−トリジン)
(酸化型o−トリジン)
この場合、反応の中間に、0−トリジンのカチオンラジ
カルが生成され、これが発色(緑色:λmax 630
nm)する原因となっている。(0-tolidine) (oxidized o-tolidine) In this case, a cation radical of 0-tolidine is generated during the reaction, which produces color (green: λmax 630
nm).
試薬層中には、例えば結合剤や粘稠剤として用いられる
高分子ポリマーや界面活性剤等が共存するが、これらの
薬剤中には、酸化剤、反応開始剤、重合開始剤等の不可
避的不純物が残留しており、この不純物が他の共存物質
と反応してラジカル等が生成され、これが0−トリジン
を酸化し発色させる。In the reagent layer, for example, high molecular weight polymers and surfactants used as binders and thickening agents coexist, but these agents contain unavoidable substances such as oxidizing agents, reaction initiators, and polymerization initiators. Impurities remain, and these impurities react with other coexisting substances to generate radicals, which oxidize 0-tolidine and cause color development.
そして、このような発色は、温度、湿度、光等の環境条
件によって促進されることもある。Such color development may be promoted by environmental conditions such as temperature, humidity, and light.
そこで、本発明は、保存中において発色の原因となるラ
ジカルを捕獲し、失活させる遊離基捕獲剤を試薬層中に
添加することにより、経時安定性の向上を図った。Therefore, the present invention aims to improve stability over time by adding a free radical scavenger to the reagent layer that captures and deactivates radicals that cause color development during storage.
〈実施例〉
以下、本発明の試験具を、添付図面に示す好適実施例に
基づいて詳細に説明する。<Example> Hereinafter, the test device of the present invention will be described in detail based on a preferred example shown in the accompanying drawings.
第1図は、本発明の試験具の構成例を示す断面正面図で
ある。 同図に示すように、試験具1は、支持体2の片
面上に試薬層3を設置したものである。FIG. 1 is a cross-sectional front view showing an example of the configuration of the test device of the present invention. As shown in the figure, the test device 1 has a reagent layer 3 disposed on one side of a support 2.
支持体2は、例えば厚さが20〜500μs程度の板状
をなしており、検体に対して不活性な材料で構成されて
いる。The support 2 has a plate shape with a thickness of, for example, about 20 to 500 μs, and is made of a material that is inert to the specimen.
支持体2の具体的な構成材料としては、ポリエチレンテ
レフタレート、セルロースエステル(セルロースジアセ
テート、セルローストリアセテート、セルロースアセテ
ートプロピオネート等)、ビスフェノールAのポリカー
ボネート、ポリメチルメタクリレート、ポリ塩化ビニル
、ポリプロピレン、ポリスチレン、ポリビニルアルコー
ル等の各種樹脂、またはガラス等が挙げられる。 また
、支持体2は、上記のうち、2種以上の材料によるシー
トを積層したものでもよい。Specific constituent materials of the support 2 include polyethylene terephthalate, cellulose ester (cellulose diacetate, cellulose triacetate, cellulose acetate propionate, etc.), polycarbonate of bisphenol A, polymethyl methacrylate, polyvinyl chloride, polypropylene, polystyrene, Examples include various resins such as polyvinyl alcohol, glass, and the like. Further, the support 2 may be a stack of sheets made of two or more of the above materials.
試薬層3は、担体に後述する試薬を担持したもので構成
される。The reagent layer 3 is composed of a carrier supporting a reagent to be described later.
この担体としては、非繊維性または繊維性の多孔質材で
構成されたものが好ましい。The carrier is preferably made of a non-fibrous or fibrous porous material.
非繊維性多孔質材としては、濾紙やメンブランフィルタ
−が代表的であり、その他、珪藻土、微結晶材料等の多
孔体を結合剤中に分散した分散物、ガラスや樹脂の微小
球形ビーズを互いに点接着させた多孔質の集合体等が挙
げられる。Typical examples of non-fibrous porous materials include filter paper and membrane filters, as well as dispersions of porous materials such as diatomaceous earth and microcrystalline materials dispersed in a binder, and microspherical beads of glass or resin that are bonded to each other. Examples include porous aggregates bonded at points.
また、繊維性多孔質材としては、織物または編物、不織
布、短繊維の集合体等が挙げられる。Furthermore, examples of the fibrous porous material include woven or knitted fabrics, nonwoven fabrics, short fiber aggregates, and the like.
繊維の素材としては、木綿、絹、ウール等の天然繊維ま
たは、ガラス、ナイロン等の樹脂等が挙げられる。Examples of the fiber material include natural fibers such as cotton, silk, and wool, and resins such as glass and nylon.
担体の厚さ、すなわち試薬層3の厚さは、特に限定され
ないが、O,1〜2mm程度、特に0.2〜1IIII
l程度とするのが好ましい。The thickness of the carrier, that is, the thickness of the reagent layer 3 is not particularly limited, but is about 0.1 to 2 mm, particularly 0.2 to 1III.
It is preferable to set it to about 1.
試薬の組成は、検体中の検出(定量)すべき特定成分に
より適宜決定される。 例えば、検体中のブドウ糖を検
出する場合には、酵素であるグルコースオキシダーゼ(
COD)およびペルオキシダーゼ(poD)と、発色剤
(色原体)とが試薬の主成分である。 また、検体中の
総コレステロール量を測定する場合には、酵素であるコ
レステロールエステラーゼ(COE) コレステロー
ルオキシダーゼ(COD)およびペルオキシダーゼと、
発色剤とが試薬の主成分である。The composition of the reagent is appropriately determined depending on the specific component to be detected (quantified) in the specimen. For example, when detecting glucose in a sample, the enzyme glucose oxidase (
COD) and peroxidase (poD), and a color former (chromogen) are the main components of the reagent. In addition, when measuring the total cholesterol amount in a sample, the enzymes cholesterol esterase (COE), cholesterol oxidase (COD), and peroxidase,
The color former is the main component of the reagent.
なお、その他のものとしては、上記酵素に代り、ウリカ
ーゼとペルオキシダーゼ、リボプロティンリパーゼおよ
びグリセロールオキシダーゼとペルオキシダーゼ、ホス
ホリパーゼDおよびコリンオキシダーゼとペルオキシダ
ーゼ等であってもよい。In addition, other enzymes may be used instead of the above enzymes, such as uricase and peroxidase, riboprotein lipase and glycerol oxidase and peroxidase, phospholipase D, choline oxidase and peroxidase.
発色剤としては、ロイコ色素が用いられ、例えば、o−
トリジン、m−トリジン、ベンジジン、3,3° 5
.5°−テトラメチルベンジジン、0−メチルベンジジ
ン、0−ジアニシジン等のベンジジンまたはベンジジン
系化合物、2.7−ジアミツフルオレン、4.4°−ジ
アミノジフェニル、0−フェニレンジアミン、m−フェ
ニレンジアミン、p−フェニレンジアミン、2.3−)
リレンジアミン、2.4−)リレンジアミン、2.5−
hリレンジアミン、2.6−ドリレンジアミン等の種々
の置換フェニレンジアミン類、無性没食子酸、没食子酸
、フロログルシノール、ヒドロキノン、ロイコインドフ
ェノール等のフェノール類、グアイヤコール、ピリジン
誘導体、置換アジン類、ロイコマラカイトグリーン等が
挙げられる。Leuco dyes are used as coloring agents, such as o-
Tolidine, m-tolidine, benzidine, 3,3° 5
.. Benzidine or benzidine compounds such as 5°-tetramethylbenzidine, 0-methylbenzidine, 0-dianisidine, 2.7-diamitsufluorene, 4.4°-diaminodiphenyl, 0-phenylenediamine, m-phenylenediamine, p -phenylenediamine, 2.3-)
lylenediamine, 2.4-) lylenediamine, 2.5-
Various substituted phenylene diamines such as lylene diamine and 2,6-lylene diamine, phenols such as amorphous gallic acid, gallic acid, phloroglucinol, hydroquinone, and leucoindophenol, guaiacol, pyridine derivatives, substituted azines, Examples include leucomalachite green.
このようなロイコ色素は、ラジカルによる影響を受は易
く、保存中等に発色し易いため、本発明を適用するのに
有効である。Such leuco dyes are easily affected by radicals and easily develop color during storage, so they are effective in applying the present invention.
上記ベンジジンまたはベンジジン系化合物は、ロイコ色
素のなかでも、特に保存中等に発色し易いため、本発明
を適用するのに好ましい。Among the leuco dyes, the benzidine or benzidine-based compound is particularly easy to develop color during storage, and is therefore preferable for application of the present invention.
このような試薬層3中には、遊離基捕獲剤(ラジカルス
カベンジャー)が添加される。A free radical scavenger is added to such a reagent layer 3.
これにより、ラジカル等のロイコ色素の発色に影響のあ
る物質が捕獲、失活され、経時安定性が向上する。As a result, substances such as radicals that affect the color development of the leuco dye are captured and deactivated, and stability over time is improved.
この遊離基捕獲剤としては、ジチオエリスリトール、ジ
チオスレイトール、グルタチオン、2−メルカプトエタ
ノール等、またはこれらと同様の機能を有する種々のも
のが挙げられるが、そのなかでも、ジチオエリスリトー
ル、ジチオスレイトールおよびグルタチオンが特に有効
であり好ましい。Examples of the free radical scavenger include dithioerythritol, dithiothreitol, glutathione, 2-mercaptoethanol, etc., and various substances having similar functions, among which dithioerythritol, dithiothreitol and Glutathione is particularly effective and preferred.
なお、これらの遊離基捕獲剤は、ラジカルを捕獲する機
能の他に、試薬層3中に共存する酵素の機能を安定化す
る作用を有する。 すなわち、酵素中には、各種金属イ
オンが含まれており、これが酸化されると酵素が失活す
るが、遊離基捕獲剤が酵素中の金属イオンの酸化を防ぎ
、酵素活性を維持するので、測定時に適正な呈色反応が
得られる。In addition to the function of capturing radicals, these free radical trapping agents have the function of stabilizing the function of enzymes coexisting in the reagent layer 3. In other words, enzymes contain various metal ions, and when these are oxidized, the enzyme becomes inactive, but the free radical scavenger prevents the oxidation of the metal ions in the enzyme and maintains the enzyme activity. Appropriate color reaction can be obtained during measurement.
このような活性維持効果のある酵素としては、例えば、
ペルオキシダーゼ、グルコースオキシダーゼ、コレステ
ロールエステラーゼ、コレステロールオキシダーゼ、グ
リセロールオキシダーゼ、コリンオキシグーゼ、ウレア
ーゼ、クレアチンアミジノヒドロラーゼ、ビログルタミ
ルペブチグーゼ、プロトカテキュエート3゜4−ジオキ
シゲナーゼ、プロリンデヒドロゲナーゼ、ロイシンデヒ
ドロゲナーゼ、グルタチオンペルオキシダーゼ、β−グ
ルコシダーゼ、α−グルコシダーゼ等が挙げられる。Examples of enzymes that have the effect of maintaining activity are, for example,
Peroxidase, glucose oxidase, cholesterol esterase, cholesterol oxidase, glycerol oxidase, choline oxygase, urease, creatine amidinohydrolase, biroglutamyl peptigase, protocatechuate 3゜4-dioxygenase, proline dehydrogenase, leucine dehydrogenase, glutathione Examples include peroxidase, β-glucosidase, α-glucosidase, and the like.
遊離基捕獲剤の添加量は、試薬層3中のラジカルを十分
に捕獲でき、かつ測定時の呈色反応を阻害しない程度と
するのがよ(、具体的には、試薬層1m”当たり1〜1
000mg、特に10〜100mgとするのが好ましい
。The amount of the free radical scavenger added should be such that it can sufficiently capture the radicals in the reagent layer 3 and not inhibit the color reaction during measurement (specifically, 1 m2 of the reagent layer). ~1
000 mg, especially 10 to 100 mg.
また、試薬層3には、必要に応じ、pH調整剤、界面活
性剤(湿潤剤)、光反射性物質、安定剤、増感剤、粘稠
剤等が添加されていてもよい。Moreover, a pH adjuster, a surfactant (wetting agent), a light-reflecting substance, a stabilizer, a sensitizer, a viscosity agent, etc. may be added to the reagent layer 3 as necessary.
pH調整剤としては、リン酸緩衝液、クエン酸緩衝液、
ホウ酸緩衝液、トリス緩衝液、グツド緩衝液等が挙げら
れる。As a pH adjuster, phosphate buffer, citrate buffer,
Examples include borate buffer, Tris buffer, Gud buffer, and the like.
界面活性剤(湿潤剤)は、試薬層3と検体とが接触した
とき、検体液が均一に湿潤(浸透)するためのものであ
り、ポリビニルピロリドン、コール酸ナトリウム、ラウ
リル硫酸ナトリウム、ドデシル硫酸ナトリウム、テトラ
デシル硫酸ナトリウム等のアルキル硫酸塩、ドデシルベ
ンゼンスルホン酸ナトリウム等のアルキルベンゼンスル
ホン酸塩、ジオクチルスルホコハク酸ナトリウム、ジブ
チルスルホコハク酸ナトリムウム、ジー2−エチルへキ
シルスルホコハク酸ナトリウム(Aerosol−OT
)等のジアルキルスルホコハク酸塩等が挙げられる。The surfactant (wetting agent) is used to uniformly wet (penetrate) the sample liquid when the reagent layer 3 and the sample come into contact, and includes polyvinylpyrrolidone, sodium cholate, sodium lauryl sulfate, and sodium dodecyl sulfate. , alkyl sulfates such as sodium tetradecyl sulfate, alkyl benzene sulfonates such as sodium dodecylbenzenesulfonate, sodium dioctyl sulfosuccinate, sodium dibutyl sulfosuccinate, sodium di-2-ethylhexyl sulfosuccinate (Aerosol-OT)
) and other dialkyl sulfosuccinates.
光反射物質は、検体が全血である場合に、赤血球による
色濃度測定への影響を排除するためのものであり、酸化
チタン、硫酸バリウム、アルミニウム、各種セラミック
ス等の微粒子が挙げられる。The light-reflecting substance is used to eliminate the influence of red blood cells on color density measurement when the sample is whole blood, and includes fine particles such as titanium oxide, barium sulfate, aluminum, and various ceramics.
安定剤は、呈色後の呈色安定性を向上するためのもので
あり、メチルビニルエーテルと無水マレイン酸の共重合
体、あるいはそのハーフエチルエステル等が挙げられる
。The stabilizer is for improving color stability after coloring, and includes a copolymer of methyl vinyl ether and maleic anhydride, a half ethyl ester thereof, and the like.
増感剤は、ペルオキシダーゼによる発色剤の発色反応の
活性等を増強させるものであり、キノリンおよびその誘
導体、例えば、キニーネ、シンコニン、6−メドキシキ
ノリン、キナルジン、8−アミノ−6−メドキシキノリ
ン、2−キノリツール、イソキノリン、ベンゾ(f)キ
ノリン、3−アミノキノリン等が挙げられる。The sensitizer enhances the activity of the coloring reaction of the coloring agent by peroxidase, and includes quinoline and its derivatives, such as quinine, cinchonine, 6-medoxyquinoline, quinaldine, 8-amino-6-medoxyquinoline. , 2-quinolitool, isoquinoline, benzo(f)quinoline, 3-aminoquinoline, and the like.
このような増感剤が存在すると、通常酸化反応が促進さ
れ、かつ酸化された発色剤の呈色強度が増大し、試験具
の感度は高められる。The presence of such a sensitizer usually accelerates the oxidation reaction and increases the color intensity of the oxidized color former, thereby increasing the sensitivity of the test device.
粘稠剤は、試薬層3の担体からの薬剤の流出を防止する
ためのものであり、ポリビニルアルコール、ポリビニル
ピロリドン、ポリエチレングリコール、アクリル酸塩、
ポリアクリルアミド、ポリ(ヒドロキシエチルメタクリ
レート) ポリ(ヒドロキシエチルアクリレート) カ
ルボキシメチルセルロース等の重合体、ゼラチン、アラ
ビアゴム等が挙げられる。The thickening agent is for preventing the drug from flowing out from the carrier of the reagent layer 3, and includes polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, acrylate,
Examples include polymers such as polyacrylamide, poly(hydroxyethyl methacrylate), poly(hydroxyethyl acrylate), carboxymethyl cellulose, gelatin, and gum arabic.
上記試薬(添加剤を含む)の担体への担持方法としては
、試薬を含有する液体を担体に含浸(例えば、担体を浸
漬液に浸漬)させ、その後、これを乾燥することにより
行えばよい。The above reagent (including additives) may be supported on a carrier by impregnating the carrier with a liquid containing the reagent (e.g., immersing the carrier in an immersion liquid), and then drying it.
液体が2種以上の場合には、含浸、乾燥を繰り返し行う
。When there are two or more types of liquids, impregnation and drying are repeated.
なお、このような試薬層3は、支持体2の表面に、例え
ば両面粘着テープ(図示せず)、接着剤またはその他挟
持器具(例えば、特願昭63−334198号に記載の
保持部材)等により固定される。Note that such a reagent layer 3 can be formed by applying, for example, double-sided adhesive tape (not shown), adhesive, or other holding device (for example, the holding member described in Japanese Patent Application No. 63-334198) to the surface of the support 2. Fixed by
また、試薬層3は、試薬等を含有する液体を支持体2の
表面に塗布、乾燥して得られたものでもよい。Further, the reagent layer 3 may be obtained by applying a liquid containing a reagent or the like to the surface of the support 2 and drying it.
この場合、試薬層3は、例えばゼラチン、ポリビニルア
ルコール、ポリビニルピロリドン、アガロース、ポリビ
ニルベンゼンスルホン酸ナトリウム、ポリウレタン、ポ
リビニルプロピオネート等の親水性結合剤(バインダー
)中に所定の試薬等を含有(分散)せしめた組成物で構
成される。In this case, the reagent layer 3 contains (disperses) a predetermined reagent in a hydrophilic binder such as gelatin, polyvinyl alcohol, polyvinylpyrrolidone, agarose, sodium polyvinylbenzenesulfonate, polyurethane, or polyvinylpropionate. ) consists of a diluted composition.
このような塗布型の試薬層3には、前記各種添加剤の他
に、硬膜剤(架橋剤)が添加されていてもよい。In addition to the various additives described above, a hardening agent (crosslinking agent) may be added to such a coating type reagent layer 3.
硬膜剤としては、ゼラチン等を架橋させるものであり、
例えば、N、N’ −へキサメチレン−1,6−ビス(
1−アジリジンカルボキサミド)(HDU) トリ
メチロルブロバンートリーβ−アジリジニルプロピオネ
ート(TAZM) 、テトラメチコルメタン−トリーβ
−アジリジニルプロピオネート(TAZO)等のアジリ
ジンの誘導体が挙げられる。As a hardening agent, it crosslinks gelatin etc.
For example, N,N'-hexamethylene-1,6-bis(
1-aziridinecarboxamide) (HDU), trimethylolbroban tri-β-aziridinylpropionate (TAZM), tetramethicolmethane-tri-β
-Aziridine derivatives such as aziridinyl propionate (TAZO).
このような塗布型の試薬層の厚さ(乾燥膜厚)は、特に
限定されないが、1〜100p程度、特に5〜30−程
度とするのが好ましい。The thickness (dry film thickness) of such a coating type reagent layer is not particularly limited, but it is preferably about 1 to 100 p, particularly about 5 to 30 p.
なお、図示の例では、試薬層3は1層のみであるが、各
々組成の異なる試薬の成分を含む複数の試薬層を積層し
たものでもよい。 特に、前記光反射性物質を分散した
層(光反射層)を試薬層3の表面に別途設けてもよい。In the illustrated example, there is only one reagent layer 3, but a plurality of reagent layers each containing reagent components of different compositions may be laminated. In particular, a layer in which the light-reflecting substance is dispersed (light-reflecting layer) may be separately provided on the surface of the reagent layer 3.
以上、本発明の試験具を図示の構成例について説明した
が、本発明は、これらに限定されるものではない。 特
に、試験具の層構成については、任意のものが可能であ
り、展開層、光反射層、吸収層(検体量調整層)、保護
層、酸化剤含有層、その他種々の目的で設けられた層が
あってもよい。Although the test device of the present invention has been described above with reference to the configuration example shown in the drawings, the present invention is not limited thereto. In particular, the layer structure of the test device can be arbitrary, and may include a developing layer, a light reflecting layer, an absorbing layer (sample amount adjustment layer), a protective layer, an oxidizing agent-containing layer, and other layers provided for various purposes. There may be layers.
なお、本発明の試験具の用途は、検体(例えば、全血、
血漿、血清、尿、糞便、唾液、リンパ液、髄液等の体液
)中のブドウ糖やコレステロールの検出に限らず、その
他、BUN、クレアチニン、カルシウム、シュウ酸、ト
リグリセリド(中性脂肪)、遊離脂肪酸、ケトン体、ビ
リルビン、ウロビリノーゲン、蛋白質、亜硝酸塩、アス
コルビン酸、ヘモグロビン、ミオグロビン、白血球、G
OT%GPT1ALP、γ−GTP等の検出にも適用可
能であり、さらに食品や環境試料の分析等の他の分野へ
の応用も可能である。The test device of the present invention is used for testing specimens (e.g. whole blood,
In addition to detecting glucose and cholesterol in body fluids such as plasma, serum, urine, feces, saliva, lymph, and cerebrospinal fluid, it also detects BUN, creatinine, calcium, oxalic acid, triglycerides (neutral fats), free fatty acids, Ketone bodies, bilirubin, urobilinogen, protein, nitrite, ascorbic acid, hemoglobin, myoglobin, white blood cells, G
It can also be applied to the detection of OT%GPT1ALP, γ-GTP, etc., and can also be applied to other fields such as analysis of food and environmental samples.
〈実施例〉 以下、本発明の実施例について説明する。<Example> Examples of the present invention will be described below.
(実施例1)
下記に示す組成の溶液1および2を調製し、厚さ約0.
32mmの編物(セーレン■製T−1000)に、まず
溶液1を含浸、乾燥(40℃、60分)し、次いで溶液
2を含浸、乾燥(40℃、5分)した。(Example 1) Solutions 1 and 2 having the composition shown below were prepared, and the thickness was about 0.
A 32 mm knitted fabric (T-1000 manufactured by Seiren ■) was first impregnated with Solution 1 and dried (40°C, 60 minutes), and then impregnated with Solution 2 and dried (40°C, 5 minutes).
その後、これを9mmX13mmのサイズに裁断し、厚
さ0.3mmのポリスチレン製シートの支持体に両面粘
着テープを用いて貼着し、血中総コレステロール量測定
用試験具を得た。Thereafter, this was cut into a size of 9 mm x 13 mm and adhered to a polystyrene sheet support with a thickness of 0.3 mm using double-sided adhesive tape to obtain a test device for measuring the total amount of cholesterol in blood.
なお、この試験具における遊離基捕獲剤の担持量は、試
薬層1+a″当たり30mgである。The amount of free radical scavenger supported in this test device was 30 mg per reagent layer 1+a''.
1藍ユ
ポリエチレングリコール4000 60mgコ
レステロールエステラーゼ 2000uコレステ
ロールオキシダーゼ 500uペルオキシダー
ゼ 11000uIリン駿緩衝液(p
i(6、0) 1.5mj蒸留水
4.5mjジチオエリスリトール
(遊離基捕獲剤) IIIg溶i
ス
3.3’、5.5−テトラメチルベンジジン 70田
g(発色剤)
Aerosol−OT (界面活性剤)
100mgアセトン 7
mC(実施例2)
溶液l中の遊離基捕獲剤をジチオスレイトール:1mg
に代えた以外は実施例1と同様とした。1 indigo polyethylene glycol 4000 60mg cholesterol esterase 2000u cholesterol oxidase 500u peroxidase 11000uI Linshun buffer (p
i(6,0) 1.5mj distilled water
4.5mj dithioerythritol (free radical scavenger) IIIg soluble i
3.3',5.5-tetramethylbenzidine 70 g (color former) Aerosol-OT (surfactant)
100mg acetone 7
mC (Example 2) Dithiothreitol: 1 mg of free radical scavenger in solution 1
The procedure was the same as in Example 1 except that .
(実施例3)
溶液1中の遊離基捕獲剤をグルタチオン:4mgに代え
た以外は実施例1と同様とした。(Example 3) The procedure was the same as in Example 1 except that the free radical scavenger in Solution 1 was replaced with 4 mg of glutathione.
(実施例4)
溶液1中の遊離゛基捕獲剤を2−メルカプトエタノール
:1mgに代えた以外は実施例1と同様とした。(Example 4) The procedure was the same as in Example 1 except that the free radical scavenger in Solution 1 was replaced with 2-mercaptoethanol (1 mg).
(実施例5)
溶液2中の発色剤を0−トリジンニア0mgに代えた以
外は実施例1と同様とした。(Example 5) The procedure was the same as in Example 1 except that the coloring agent in Solution 2 was replaced with 0 mg of 0-tridinenia.
(比較例)
溶液1中に遊離基捕獲剤を含有しない以外は実施例1と
同様とした。(Comparative Example) The same procedure as Example 1 was carried out except that Solution 1 did not contain a free radical scavenger.
上記本発明の実施例1〜5および比較例の各試験具を明
室、温度22℃、湿度65%RHの条件下で長時間保存
した。Each test device of Examples 1 to 5 of the present invention and the comparative example was stored for a long time in a bright room at a temperature of 22° C. and a humidity of 65% RH.
これらについて試薬層の呈色状況を肉眼で随時調べたと
ころ、実施例1〜5の試験具は、いずれも、5時間経過
しても全(発色は認められず、保存性は良好であったが
、比較例の試験具では、5時間経過したとき、緑色の発
色が認められた。When the coloring status of the reagent layer was examined with the naked eye, all of the test devices of Examples 1 to 5 showed that no coloring was observed even after 5 hours had passed, and the storage stability was good. However, in the test device of the comparative example, green color development was observed after 5 hours had passed.
さらに、実施例1および比較例の試験具について試薬層
の表面に対し45°の角度で2方向から白色光を照射し
、その反射光(試薬層表面に対し直角方向)のスペクト
ルを測定した。Further, for the test devices of Example 1 and Comparative Example, the surface of the reagent layer was irradiated with white light from two directions at an angle of 45°, and the spectrum of the reflected light (direction perpendicular to the surface of the reagent layer) was measured.
その結果を第5図のグラフに示す。The results are shown in the graph of FIG.
なお、測定に用いた装置は、大塚電子■製MCPD−2
00型であった。The device used for the measurement was MCPD-2 manufactured by Otsuka Electronics.
It was type 00.
同図に示すように、比較例ではラジカルによる発色(極
大波長670 nm)が認められているが、実施例1で
はラジカルが捕獲、失活しているため、はとんど発色し
ていない。As shown in the figure, color development due to radicals (maximum wavelength 670 nm) was observed in the comparative example, but in Example 1, the radicals were captured and deactivated, so no color was developed at all.
また、実施例1〜5の各試験具に対し、コレステロール
濃度がそれぞれ50.100.200.300.400
および500 mg/djに調整された血清サンプルを
用いてコレステロール濃度の測定を行なったところ、い
ずれの試験具においても、測定値にほとんど差がなく、
正常な測定を行なうことができた。In addition, for each test device of Examples 1 to 5, the cholesterol concentration was 50.100.200.300.400.
When cholesterol concentration was measured using serum samples adjusted to 500 mg/dj and 500 mg/dj, there was almost no difference in the measured values with either test device.
I was able to perform normal measurements.
〈発明の効果〉
以上述べたように、本発明の試験具によれば、経時安定
性に優れ、長時間保存しても発色を生じない。<Effects of the Invention> As described above, the test device of the present invention has excellent stability over time and does not develop color even when stored for a long time.
また、検体中の特定物質の検出、測定に際し、呈色反応
に悪影響を及ぼすことな(、適正な検出、測定を行なう
ことができる。In addition, when detecting and measuring a specific substance in a specimen, it is possible to perform proper detection and measurement without adversely affecting the color reaction.
第1図は、本発明の試験具の構成例を示す断面正面図で
ある。
第2図は、試薬層の反射スペクトルを示すグラフである
。
符号の説明
1・・・試験具
2・・・支持体
3・・・試薬層
願
理
同
テ ルFIG. 1 is a cross-sectional front view showing an example of the configuration of the test device of the present invention. FIG. 2 is a graph showing the reflection spectrum of the reagent layer. Explanation of symbols 1...Test device 2...Support 3...Reagent layer
Claims (4)
薬層を有する試験具であって、 前記試薬層中に、遊離基捕獲剤を含有することを特徴と
する試験具。(1) A test device having a reagent layer supporting a reagent containing a leuco dye as a coloring agent, characterized in that the reagent layer contains a free radical scavenger.
系化合物である請求項1に記載の試験具。(2) The test device according to claim 1, wherein the leuco dye is benzidine or a benzidine-based compound.
チオスレイトール、グルタチオンおよび2−メルカプト
エタノールよりなる群から選ばれた少なくとも1種であ
る請求項1または2に記載の試験具。(3) The test device according to claim 1 or 2, wherein the free radical scavenger is at least one selected from the group consisting of dithioerythritol, dithiothreitol, glutathione, and 2-mercaptoethanol.
2当り、1〜1000mgである請求項1〜3のいずれ
かに記載の試験具。(4) The amount of the free radical scavenger added is 1 m^ of the reagent layer.
The test device according to any one of claims 1 to 3, wherein the amount is 1 to 1000 mg/2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22587690A JPH04106469A (en) | 1990-08-28 | 1990-08-28 | Testing device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22587690A JPH04106469A (en) | 1990-08-28 | 1990-08-28 | Testing device |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04106469A true JPH04106469A (en) | 1992-04-08 |
Family
ID=16836246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22587690A Pending JPH04106469A (en) | 1990-08-28 | 1990-08-28 | Testing device |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04106469A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004361397A (en) * | 2003-05-09 | 2004-12-24 | Japan Science & Technology Agency | Apparatus for measuring multiple kinds of ions |
-
1990
- 1990-08-28 JP JP22587690A patent/JPH04106469A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004361397A (en) * | 2003-05-09 | 2004-12-24 | Japan Science & Technology Agency | Apparatus for measuring multiple kinds of ions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1143132C (en) | Blood sugar detecting strip available for perusal | |
JP3686326B2 (en) | Test piece for measuring high density lipoprotein (HDL) cholesterol | |
JPS596900A (en) | Analytical element and method of measuring high glucose and method and system for measuring sugar content of whole blood using same | |
JP3406089B2 (en) | Dry analytical element containing amphoteric electrolyte | |
JPH0230466B2 (en) | ||
JPH0431675B2 (en) | ||
GB2104215A (en) | A material for the analysis of a liquid sample | |
JPH04637B2 (en) | ||
JPH04324347A (en) | Testing device | |
JPS584555B2 (en) | Ascorbic acid detection composition, detection method, and detection element | |
EP0158964B1 (en) | Tester for detecting a substance in a body fluid | |
JPH04636B2 (en) | ||
EP0322882B1 (en) | Integral multilayer analytical element | |
JPH04106469A (en) | Testing device | |
JPS6259782B2 (en) | ||
JP3843294B2 (en) | Test pieces | |
JPH0253897A (en) | Purified guaiacum resin and production thereof | |
JP3704550B2 (en) | Dry measurement test element | |
JP4493535B2 (en) | Test paper | |
JPH05260994A (en) | Detection of analyte in saliva using peroxide-peroxidase test system | |
USH600H (en) | Whole blood analytical element and method of analyzing whole blood using the same | |
JPH04102059A (en) | Test jig | |
JPH03103194A (en) | Testing agent and testing tool | |
JPS63163164A (en) | Multi-layer analysis element | |
JPH01101453A (en) | Detection of material to be analyzed |